✦ LIBER ✦

Profiles of circulating cytokines in patients with Crohn's disease under maintenance therapy with infliximab

✍ Scribed by Kotaro Ogawa; Takayuki Matsumoto; Motohiro Esaki; Takehiro Torisu; Mitsuo Iida

Book ID: 119223427
Publisher: Oxford University Press
Year: 2012
Tongue: English
Weight: 421 KB
Volume: 6
Category: Article
ISSN: 1873-9946
DOI: 10.1016/j.crohns.2011.10.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P279 Circulating cytokines profiles in c

P279 Circulating cytokines profiles in children with inflammatory bowel disease under infliximab therapy

✍ Kuznetsova, L.; Petrichuk, S.; Potapov, A.; Tsimbalova, E. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 111 KB

Retreatment and maintenance therapy with

Retreatment and maintenance therapy with infliximab in fistulising Crohn's disease

✍ Rodrigo, Luis; Perez-Pariente, Jm.; Cadahia, V.; Fuentes, D.; Nino, P.; Francisc 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Efficacy of Enteral Nutrition During Inf

Efficacy of Enteral Nutrition During Infliximab Maintenance Therapy in Patients with Crohn’s Disease

✍ Takayuki Yamamoto, Manabu Shiraki 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 141 KB

Maintenance therapy with infliximab in t

Maintenance therapy with infliximab in the management of fistulous Crohn’s Disease

✍ Nabeel Khan; Taylor Huynh-Le; Luis A Balart 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 25 KB

Maintenance infliximab therapy in patien

Maintenance infliximab therapy in patients with crohn’s disease: how long, how much, how frequent?

✍ Carmen Cuffari; Gary R Lichtenstein 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Long-term outcome of maintenance inflixi

Long-term outcome of maintenance infliximab therapy in children with Crohn's disease

✍ Jeffrey S. Hyams; Trudy Lerer; Anne Griffiths; Marian Pfefferkorn; Subra Kugatha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 2 views

Background: Infliximab therapy has short-term benefits in children with moderate-to-severe Crohn's disease (CD). We assessed the long-term outcome of infliximab maintenance therapy in children with CD. ## Methods: We performed a multicenter cohort study of 729 pediatric patients with CD enrolled i